“That was one of my best birthdays ever,” Libby says after her friends, family and supporters gifted more than $2400 to BCAC in honour of her birthday.
We have received excellent information about COVID-19 for women with breast cancer from the Māori Cancer Leadership Group and the Cancer Control Agency, that you will find attached.
As New Zealand moves to halt the spread of the new flu-like virus COVID-19 (Coronavirus), we have pulled together this information for New Zealanders with breast cancer and their families and whānau. This virus can affect lungs and airways, and has been declared a pandemic by the World Health Organisation.
BCAC media release - 5 March 2020
It is fantastic news that funding for a vital drug for women with advanced breast cancer, palbociclib (Ibrance), will cover the costs for all those who need it , Libby Burgess, Chair of the Breast Cancer Aotearoa Coalition (BCAC) says.
A clinical trial shows that tucatinib, an investigative therapy used in combination with trastuzumab and capecitabine, reduces risk of death at two years by one-third in women with HER2-positive metastatic breast cancer (HER2+ MBC).